Tandem Diabetes Care (TNDM) EBITDA Margin (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly EBITDA Margin came in at 7.05% in Q1 2026, up 4451.0% YoY from 0.15% in Q1 2025, and down 346.9% on a QoQ basis from 2.86% in Q4 2025.
Tandem Diabetes Care (TNDM) EBITDA Margin (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of EBITDA Margin data on file, last reported at 7.05% in Q1 2026.
- Quarterly EBITDA Margin rose 4451.0% year-over-year to 7.05% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.16% (up 999.0% YoY) and the FY2025 annual result came in at 18.45%, down 791.0% from the prior year.
- EBITDA Margin slipped to 7.05% in Q1 2026, from 2.86% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 2.86% in Q4 2025 to a low of 75.46% in Q1 2023.
- A 5-year average of 18.19% and a median of 13.87% in 2024 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2023 — EBITDA Margin sank 6674 bps — and 2024, when it surged 5372 bps.
- Tracing TNDM's EBITDA Margin over 5 years: stood at 8.06% in 2022, then tumbled by 121 bps to 17.82% in 2023, then surged by 99 bps to 0.21% in 2024, then surged by 1490 bps to 2.86% in 2025, then sank by 347 bps to 7.05% in 2026.
- The last three EBITDA Margin figures came in at 7.05% (Q1 2026), 2.86% (Q4 2025), and 9.17% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 19.15% |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.11 Bn | 144.78 Mn | -5.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.42% |
| Mar 31, 2026 | -7.05% |
| Dec 31, 2025 | 2.86% |
| Sep 30, 2025 | -9.17% |
| Jun 30, 2025 | -21.53% |
| Mar 31, 2025 | -51.56% |
| Dec 31, 2024 | -0.21% |
| Sep 30, 2024 | -10.70% |
| Jun 30, 2024 | -13.87% |
| Mar 31, 2024 | -21.74% |
| Dec 31, 2023 | -17.82% |
| Sep 30, 2023 | -16.99% |
| Jun 30, 2023 | -19.81% |
| Mar 31, 2023 | -75.46% |
| Dec 31, 2022 | -8.06% |
| Sep 30, 2022 | -23.22% |
| Jun 30, 2022 | -6.11% |
| Mar 31, 2022 | -8.72% |
| Dec 31, 2021 | 6.07% |
| Sep 30, 2021 | 4.30% |